Chadrick Denlinger to Protease Inhibitors
This is a "connection" page, showing publications Chadrick Denlinger has written about Protease Inhibitors.
Connection Strength
0.074
-
Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004 Apr; 127(4):1078-86.
Score: 0.057
-
Novel targeted therapies for non-small cell lung cancer. Thorac Surg Clin. 2006 Nov; 16(4):353-66.
Score: 0.017